FDA expands remdesivir use for all COVID-19 hospitalized patients

An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low blood oxygen levels or who need oxygen therapy or mechanical ventilation.

Read the full article here

Related Articles